SHINGRIX® Shingles Vaccine — 1 Dose

Many people mistakenly believe that shingles only affects older adults. In fact, the varicella-zoster virus, which causes shingles, can remain dormant in the body after a previous chickenpox infection and may reactivate later in life.
As the immune system naturally weakens with age, the risk of shingles may increase, particularly among older adults and people with weakened immunity. Individuals aged over 50, people with immune system conditions, people living with HIV, and those under long-term stress may have a higher risk.
The new-generation shingles vaccine helps protect against shingles and may reduce the risk of post-herpetic neuralgia and other shingles-related complications. Clinical studies have reported protection of over 90% in certain age groups.
Vaccination may also be considered for individuals who have previously had shingles, as it may help reduce the risk of future episodes.
Recommended groups include:
 
 
Adults aged 50 or above
 
 
Adults aged 18 or above who are at increased risk, such as people with chronic illnesses, those taking long-term steroids, or individuals under significant stress or with insufficient rest